Parexel and Signify Health join hands to promote access to clinical trials

The Drugs Controller General of India (DCGI) has given nod to conduct phase 3 clinical trial of Russia’s COVID-19 vaccine candidate, Sputnik V, in India, according to Dr. Reddy’s Laboratories.

India recorded 15,151 new COVID-19 infections on Friday. The cumulative confirmed cases have now risen to 1,05,43,659, of which 2,08,261 are active infections. The nation also recorded 16,801 recoveries and 176 deaths on the day taking the total recoveries and fatalities to 1,01,78,883 and 1,52,130 respectively.

The European Commission has approved baloxavir marboxil, sold under the brand name Xofluza, for the treatment of uncomplicated influenza in patients aged 12 years and above, announced Roche.

DuPont Nutrition & Biosciences has launched Howaru Calm, a probiotic aimed at helping reduce stress. The company said that Howaru Calm’s featured strain – Lactobacillus paracasei Lpc-37, was scrupulously tested to ensure its quality, efficacy and performance.

An investigational antibody donanemab, significantly slowed reduction of cognition and daily function in early Alzheimer’s disease in the phase 2 trial, according to a press release from Eli Lilly and Company.

Equilibrium in public and private health services, increased access and affordability and close looped solutions for healthcare waste are some of the most important and immediate requirements to mitigate the risks associated with COVID-19 pandemic worldwide.